Exports to regulated markets such as the US and Europe helped drug major Alembic post a net profit of Rs 15.34 crore for the quarter ended March 31, 2008, up 38.8 per cent, compared with Rs 11.05 crore posted in the corresponding previous quarter.

<tr><td><p class='TableClas'></p><P class='TableClas'><DIV CLASS=rightDiv><script language="JavaScript">
		google_ad_client = 'businessstandard';
		//google_ad_client = 'ca-businessstandard_js';
		google_ad_width = 200;
		google_ad_height = 200;
		google_ad_format = "200x200_as";
		google_ad_type = "text";
		google_ad_channel = "";
		//google_color_border = "FFFFFF";
		google_color_border = "F7F7F7";
		//google_color_bg = "FFFFFF";
		google_color_bg = "ffffff";
		//google_color_link = "639ACE";
		google_color_link = "0253B7";
		google_color_text = "000000";
		google_color_url = "D63431";
		//google_skip = adsenseSkip;
		</script> 
		<script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
		</script> </DIV><p class='TableClas'>Sales stood at Rs 268 crore, up 58.57 per cent, compared with Rs 169 crore in the corresponding previous quarter.
</p><p class='TableClas'>Net profit for the year ended March 31, 2008, rose by 57.7 per cent to Rs 112 crore (Rs 71 crore). Net sales at Rs 1,027 crore (Rs 722 crore) jumped 42.24 per cent.
</p><p class='TableClas'>The company

Alembic Q4 net jumps 39%

More From This Section

United Spirits Q3 net up 70%

IL&FS Transportation Networks Q3 net up 18% to Rs 104 cr

Jain Irrigation Q3 net loss at Rs 31 cr

RCF posts 37% rise in Q3 net at Rs 74 cr

Explore News